Status:
NOT_YET_RECRUITING
Pilot Feasibility Study of Laryngeal Ultrasound in the Paediatric Population - ECHO LARYNX
Lead Sponsor:
University Hospital, Bordeaux
Conditions:
Laryngeal Diseases
Ultrasound
Eligibility:
All Genders
Up to 15 years
Brief Summary
Nasofibroscopy is the gold standard for laryngeal pathology diagnosis. However, this examination is invasive and can be poorly tolerated in the pediatric population. Laryngeal ultrasound appears to be...
Detailed Description
According to current knowledge, the gold standard for diagnosing laryngeal pathologies is flexible fiberoptic laryngoscopy (FFL), as it allows visualisation of the motricity of the laryngeal structure...
Eligibility Criteria
Inclusion
- patients treated in the pediatric ENT unit at Bordeaux University Hospital, aged between 0 and 15 years
Exclusion
- intubated patient,
- haemodynamic
- respiratory instability
- opposition to participation expressed by parents or patient
Key Trial Info
Start Date :
September 15 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 15 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06559293
Start Date
September 15 2024
End Date
September 15 2024
Last Update
August 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Bordeaux, Hôpital Pellegrin, Service d'oto-rhino-laryngologie, de chirurgie cervico-faciale et d'ORL pédiatrique
Bordeaux, France, 33076